The Home of the Life Sciences Industry

Explore Latest News

Jeremy Moeller/Getty Images

BMS Bets Big on Eisai's ADC for Solid Tumors in Potential $3 Billion Collab

Eisai believes this is a potential-best in class FRα ADC that has shown single agent activity in patients with advanced solid tumors, including endometrial, ovarian, lung and breast cancers.
Sean Zanni/Patrick McMullan via Getty Images

Athira CEO Placed on Temporary Leave Pending Doctoral Research Review

In its announcement, the company did not specify why Kawas’ doctoral research was under investigation, only saying it did not intend to comment on the issue until it had been resolved.

Get personalized job alerts

Create a job alert and receive custom job recommendations straight to your inbox.


Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.

Post Jobs Now